Dr. Reddy’s Laboratories Ltd ADR (NYSE:RDY) — Market Cap & Net Worth
Market Cap & Net Worth: Dr. Reddy’s Laboratories Ltd ADR (RDY)
Dr. Reddy’s Laboratories Ltd ADR (NYSE:RDY) has a market capitalization of $11.16 Billion ($11.16 Billion) as of June 17, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #2094 globally and #775 in its home market, demonstrating a 4.95% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dr. Reddy’s Laboratories Ltd ADR's stock price $13.58 by its total outstanding shares 832532930 (832.53 Million). Review RDY liabilities breakdown to assess the company's total debt and financial obligations.
Dr. Reddy’s Laboratories Ltd ADR Market Cap History: 2015 to 2026
Dr. Reddy’s Laboratories Ltd ADR's market capitalization history from 2015 to 2026. Data shows growth from $6.26 Billion to $11.10 Billion (2.02% CAGR).
Index Memberships
Dr. Reddy’s Laboratories Ltd ADR is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ARCA Pharmaceutical
DRG
|
$3.26 Trillion | 0.34% | #15 of 24 |
Weight: Dr. Reddy’s Laboratories Ltd ADR's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Dr. Reddy’s Laboratories Ltd ADR Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dr. Reddy’s Laboratories Ltd ADR's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Dr. Reddy’s Laboratories Ltd ADR's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.21x
Dr. Reddy’s Laboratories Ltd ADR's market cap is 0.21 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.30 Billion | $154.71 Billion | $20.01 Billion | 0.04x | 0.31x |
| 2017 | $5.26 Billion | $140.81 Billion | $12.04 Billion | 0.04x | 0.44x |
| 2018 | $5.33 Billion | $142.03 Billion | $9.81 Billion | 0.04x | 0.54x |
| 2019 | $5.78 Billion | $153.85 Billion | $18.80 Billion | 0.04x | 0.31x |
| 2020 | $10.48 Billion | $174.60 Billion | $19.50 Billion | 0.06x | 0.54x |
| 2021 | $9.66 Billion | $2.56 Billion | $232.21 Million | 3.78x | 41.62x |
| 2022 | $7.99 Billion | $214.39 Billion | $23.57 Billion | 0.04x | 0.34x |
| 2023 | $10.91 Billion | $245.88 Billion | $45.07 Billion | 0.04x | 0.24x |
| 2024 | $13.15 Billion | $279.16 Billion | $55.68 Billion | 0.05x | 0.24x |
| 2025 | $11.69 Billion | $325.54 Billion | $56.54 Billion | 0.04x | 0.21x |
Competitor Companies of RDY by Market Capitalization
Companies near Dr. Reddy’s Laboratories Ltd ADR in the global market cap rankings as of June 17, 2026.
Key companies related to Dr. Reddy’s Laboratories Ltd ADR by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #512 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #613 globally with a market cap of $44.69 Billion USD ( CN¥305.43 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #629 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #512 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.41 |
| #613 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.69 Billion | CN¥47.88 |
| #629 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Dr. Reddy’s Laboratories Ltd ADR Historical Marketcap From 2015 to 2026
Between 2015 and today, Dr. Reddy’s Laboratories Ltd ADR's market cap moved from $6.26 Billion to $ 11.10 Billion, with a yearly change of 2.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.10 Billion | -5.06% |
| 2025 | $11.69 Billion | -11.08% |
| 2024 | $13.15 Billion | +20.51% |
| 2023 | $10.91 Billion | +36.48% |
| 2022 | $7.99 Billion | -17.29% |
| 2021 | $9.66 Billion | -7.83% |
| 2020 | $10.48 Billion | +81.45% |
| 2019 | $5.78 Billion | +8.45% |
| 2018 | $5.33 Billion | +1.26% |
| 2017 | $5.26 Billion | -16.43% |
| 2016 | $6.30 Billion | +0.61% |
| 2015 | $6.26 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of Dr. Reddy’s Laboratories Ltd ADR was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.16 Billion USD |
| MoneyControl | $11.16 Billion USD |
| MarketWatch | $11.16 Billion USD |
| marketcap.company | $11.16 Billion USD |
| Reuters | $11.16 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dr. Reddy’s Laboratories Ltd ADR
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical pr… Read more